HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Pei Selected Research

notoginsenoside ST-4

6/2011Notoginsenoside ST-4 inhibits virus penetration of herpes simplex virus in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Pei Research Topics

Disease

9Infections
10/2014 - 05/2003
2Wounds and Injuries (Trauma)
05/2020 - 10/2015
2Malaria
01/2016 - 02/2010
2Neoplasms (Cancer)
02/2015 - 07/2010
2Fibrosis (Cirrhosis)
01/2013 - 11/2004
1Fatigue
01/2021
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2020
1Heart Failure
01/2020
1Patellofemoral Pain Syndrome
01/2016
1Metabolic Diseases (Metabolic Disease)
11/2015
1Type 2 Diabetes Mellitus (MODY)
11/2015
1Insulin Resistance
11/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
07/2014
1Starvation
08/2013
1Atherosclerotic Plaque (Atheroma)
01/2013
1Myocardial Infarction
01/2013
1Atherosclerosis
01/2013
1Virus Diseases (Viral Diseases)
08/2012
1Herpes Simplex
06/2011
1Retinal Neovascularization
05/2011
1Ganglion Cysts (Ganglion)
05/2011
1Endometritis
01/2010
1Pathologic Processes
01/2010
1Immune System Diseases (Immune Disorders)
11/2008
1Inflammation (Inflammations)
11/2008
1Neuralgia (Stump Neuralgia)
11/2008

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2011
3Actins (F Actin)IBA
10/2014 - 08/2012
3Prostaglandins GIBA
10/2014 - 01/2011
3Antiviral Agents (Antivirals)IBA
10/2014 - 06/2011
2CelluloseIBA
05/2020 - 10/2015
2Glucose (Dextrose)FDA LinkGeneric
11/2015 - 10/2014
2Oxygen (Dioxygen)IBA
10/2015 - 05/2011
2pentagalloylglucoseIBA
02/2011 - 01/2011
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2010 - 11/2008
1resilinIBA
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
12/2020
1ChitosanIBA
05/2020
1pro-brain natriuretic peptide (1-76)IBA
01/2020
1Combined VaccinesIBA
01/2016
1AntigensIBA
01/2016
1NeuropeptidesIBA
01/2016
1Substance PIBA
01/2016
1Cyclin-Dependent Kinase 5IBA
11/2015
1Urea (Carbamide)FDA LinkGeneric
10/2015
1SolutionsIBA
10/2015
1GelatinIBA
10/2015
1SteamIBA
10/2015
1Blood Substitutes (Artificial Blood)IBA
02/2015
1CollagenIBA
02/2015
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
07/2014
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
07/2014
1Cysteine Proteases (Cysteine Protease)IBA
09/2013
1Cytochalasin DIBA
08/2013
1ApolipoproteinsIBA
01/2013
1Apolipoproteins E (ApoE)IBA
01/2013
1CholesterolIBA
01/2013
1CholatesIBA
01/2013
1Actin Depolymerizing Factors (Cofilins)IBA
08/2012
1Cofilin 1IBA
08/2012
1Destrin (Actin Depolymerizing Factor)IBA
08/2012
1Viral DNAIBA
07/2011
1RNA (Ribonucleic Acid)IBA
07/2011
1notoginsenoside ST-4IBA
06/2011
1Liposomes (Liposome)IBA
05/2011
12- (4- acetyloxycyclohexylamino)- 4- (3,6,6- trimethyl- 4- oxo- 4,5,6,7- tetrahydro- 1H- indazol- 1- yl)- benzamideIBA
03/2011
1Oxidoreductases (Dehydrogenase)IBA
02/2010
1Pyruvic Acid (Pyruvate)IBA
02/2010
1EnzymesIBA
02/2010
1Coloring Agents (Dyes)IBA
01/2010
1CB2 Cannabinoid ReceptorIBA
11/2008
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2004
1DefensinsIBA
05/2003
1CytokinesIBA
05/2003

Therapy/Procedure

1Nephrectomy
07/2010